Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Inventory Average (2016 - 2025)

Historic Inventory Average for Fortress Biotech (FBIO) over the last 10 years, with Q3 2025 value amounting to $13.1 million.

  • Fortress Biotech's Inventory Average rose 2172.29% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year increase of 2172.29%. This contributed to the annual value of $12.6 million for FY2024, which is 322.18% up from last year.
  • Latest data reveals that Fortress Biotech reported Inventory Average of $13.1 million as of Q3 2025, which was up 2172.29% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Inventory Average registered a high of $16.1 million during Q2 2022, and its lowest value of $1.8 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $13.0 million (2021), whereas its average is $11.9 million.
  • As far as peak fluctuations go, Fortress Biotech's Inventory Average soared by 104679.35% in 2021, and later plummeted by 2776.21% in 2023.
  • Fortress Biotech's Inventory Average (Quarter) stood at $10.7 million in 2021, then surged by 36.85% to $14.7 million in 2022, then dropped by 27.76% to $10.6 million in 2023, then grew by 25.92% to $13.4 million in 2024, then fell by 2.21% to $13.1 million in 2025.
  • Its Inventory Average was $13.1 million in Q3 2025, compared to $13.0 million in Q2 2025 and $13.7 million in Q1 2025.